LLY and VERV Related Headlines
Go Back- Lilly completes Verve Therapeutics acquisition for cardiovascular treatments
- Lilly completes acquisition of Verve Therapeutics to advance one-time treatments for people with high cardiovascular risk
- Lilly tender offer for Verve expires with 55.7% of shares tendered
- Lilly and Verve announce expiration of Verve tender offer
LLY and VERV Related Press Releases
Go Back- Lilly completes acquisition of Verve Therapeutics to advance one-time treatments for people with high cardiovascular risk
- Lilly and Verve announce expiration of Verve tender offer
